MedTrace Logo

TCAR Cerebral Protection And MicroNET-Covered Stent To Reduce Strokes

NCT04547387 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2021-01-06

No results posted yet for this study

Summary

Prospective, single center clinical study in consecutive patients with symptoms or signs of carotid stenosis related ischemic cerebral injury undergoing carotid revascularization in primary and secondary stroke prevention. MicroNET-covered stent is implanted using direct carotid artery access and temporary flow reversal to combine optimal intraprocedural cerebral protection and optimal plaque exclusion.

Conditions

  • Carotid Artery Diseases

Interventions

DEVICE

Trans-carotid access revascularization with MicroNET covered stent implantation

Implantation of the micronet covered self-expanding carotid stent during temporary cerebral flow reversal achieved with direct common carotid artery puncture

Sponsors & Collaborators

  • John Paul II Hospital, Krakow

    lead OTHER

Principal Investigators

  • Piotr Musialek, MD, DPhil · Department of Cardiac and Vascular Diseases, John Paul II Hospital

  • Mariusz Trystula, MD, PhD · Department of Vascular Surgery, John Paul II Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-10
Primary Completion
2021-03-31
Completion
2021-04-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04547387 on ClinicalTrials.gov